| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.7828 | 26 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.665 | 16 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.0068 | 27 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.7458 | 36 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.9373 | 27 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.4348 | 24 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.4042 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.5168 | 11 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.6001 | 16 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.1066 | 10 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.1675 | 42 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.5358 | 25 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.3304 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 39.1097 | 4 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 39.9995 | 6 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.3831 | 34 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 53.6015 | 57 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43 | 17 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.6831 | 16 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.2622 | 10 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.1304 | 23 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.7704 | 44 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.2245 | 10 |